世界の電気生理学市場の成長要因としては、技術の進歩、市場への新規参入、投資や資金、助成金の増加。対象疾患や手技の発生率の増加などが挙げられます。新興国市場も、この市場で事業を展開するプレーヤーに高い成長機会を提供することが期待されています。ただし、今後数年間は電気生理学製品のコストの高さ、不十分な保険適用、米国での不利な医療改革、コストがかかる新製品発売のための臨床データ要件、代替技術の利用可能性などが、成長の阻害要因になると予想されます。デバイスの再利用と再処理、および熟練した経験豊富な電気生理学者の不足が、この市場の課題です。予測期間中はCOVID-19のパンデミックも、市場の成長が一時的に鈍化する要因になると予想されます。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 20)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY USED
1.5 KEY MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 26)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.1.2 Indicative list of secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MARKET ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION METHODOLOGY
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 37)
4 PREMIUM INSIGHTS (Page No. - 41)
4.1 ELECTROPHYSIOLOGY MARKET OVERVIEW
4.2 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY INDICATION AND REGION
4.3 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY PRODUCT AND INDICATION
4.4 ELECTROPHYSIOLOGY MARKET SHARE, BY END USER, 2021 VS. 2027
4.5 GEOGRAPHICAL SNAPSHOT OF ELECTROPHYSIOLOGY MARKET
5 MARKET OVERVIEW (Page No. - 46)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 High rate of technological advancements
5.2.1.1.1 Increased use of non-invasive cardiac mapping
5.2.1.1.2 Increased use of improved intracardiac ablation systems
5.2.1.1.3 Increased use of MRI guided ablation procedures
5.2.1.1.4 Growing level of ultrasound guidance in the EP Lab
5.2.1.2 Rising number of new entrants in the market
5.2.1.3 Growing investments, funds, and grants for cardiac surgeries and electrophysiology
5.2.1.4 Increasing incidence of target diseases and procedures
5.2.2 RESTRAINTS
5.2.2.1 High cost of electrophysiology products and inadequate reimbursement process
5.2.2.2 Unfavorable healthcare reforms in the US
5.2.2.3 Cost-intensive requirement for clinical data for new product launches along with availability of alternative technologies
5.2.3 OPPORTUNITIES
5.2.3.1 Rising number of emerging markets
5.2.4 CHALLENGES
5.2.4.1 Increasing rate of reusing and reprocessing of devices
5.2.4.2 Lack of skilled and experienced electrophysiologists
5.3 REGULATORY LANDSCAPE
5.3.1 NORTH AMERICA
5.3.1.1 US
5.3.1.2 Canada
5.3.2 EUROPE
5.3.3 ASIA PACIFIC
5.3.3.1 India
5.3.3.2 China
5.3.3.3 Japan
5.4 COVID-19 IMPACT
5.5 REIMBURSEMENT SCENARIO
5.6 PATENT ANALYSIS
5.6.1 PATENTS GRANTED FOR ELECTROPHYSIOLOGY
5.6.2 JURISDICTION AND TOP APPLICANT ANALYSIS
5.7 VALUE CHAIN ANALYSIS
5.8 PRICING TREND ANALYSIS
5.9 PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 ECOSYSTEM LANDSCAPE
6 ELECTROPHYSIOLOGY MARKET, BY PRODUCT (Page No. - 73)
6.1 INTRODUCTION
6.2 ELECTROPHYSIOLOGY LABORATORY DEVICES
6.2.1 3D MAPPING SYSTEMS
6.2.1.1 Development of alternative technologies to hinder market growth
6.2.2 ELECTROPHYSIOLOGY RECORDING SYSTEMS
6.2.2.1 Increasing public-private funding to drive market growth
6.2.3 RADIOFREQUENCY (RF) ABLATION SYSTEMS
6.2.3.1 Rising number of RF ablation procedures to drive market growth
6.2.4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS
6.2.4.1 Advantages of ICE ultrasound imaging systems to drive market growth
6.2.5 ELECTROPHYSIOLOGY X-RAY SYSTEMS
6.2.5.1 Magnetic navigation systems to hamper market growth
6.2.6 ELECTROPHYSIOLOGY REMOTE MAGNETIC AND ROBOTIC NAVIGATION SYSTEMS
6.2.6.1 Favorable reimbursement scenario to drive market growth
6.3 ELECTROPHYSIOLOGY ABLATION CATHETERS
6.3.1 CRYOABLATION ELECTROPHYSIOLOGY CATHETERS
6.3.1.1 Significant therapeutic advantages to drive market growth
6.3.2 RADIOFREQUENCY (RF) ABLATION CATHETERS
6.3.2.1 Technological advancements in radiofrequency ablation catheters to drive the market
6.3.3 MICROWAVE ABLATION (MWA) SYSTEMS
6.3.3.1 Advantages of Microwave Ablation Systems over RF Ablation Catheters to drive market growth
6.3.4 LASER ABLATION SYSTEMS
6.3.4.1 Technologically advanced products to drive market growth
6.4 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.1 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.1.1 Increasing demand in emerging markets to support market growth
6.4.2 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.2.1 Advantages of Advanced Electrophysiology Diagnostic Catheters over conventional EP diagnostic catheters to drive market growth
6.4.3 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.3.1 Increased demand due to rising use of ICE ultrasound imaging systems to drive market growth
6.5 ACCESS DEVICES
6.5.1 LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS TO DRIVE MARKET GROWTH
6.6 OTHER PRODUCTS
7 ELECTROPHYSIOLOGY MARKET, BY INDICATION TYPE (Page No. - 99)
7.1 INTRODUCTION
7.2 ATRIAL FIBRILLATION
7.2.1 GROWING INITIATIVES TO SHOWCASE ADVANTAGES OF CATHETER ABLATION OVER ANTIARRHYTHMIC DRUGS TO DRIVE MARKET GROWTH
7.3 ATRIAL FLUTTER
7.3.1 HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR TREATMENT OF ATRIAL FLUTTER TO DRIVE MARKET GROWTH
7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT)
7.4.1 INCREASING VALIDATION OF EFFICACY OF ELECTROPHYSIOLOGY DEVICES FOR AVNRT TO DRIVE MARKET GROWTH
7.5 WOLFF-PARKINSON-WHITE SYNDROME (WPW)
7.5.1 PREFERENCE FOR RADIOFREQUENCY ABLATION OVER SURGERY TO TREAT WOLFF-PARKINSON-WHITE SYNDROME TO DRIVE MARKET GROWTH
7.6 OTHER INDICATIONS
8 ELECTROPHYSIOLOGY MARKET, BY END USER (Page No. - 106)
8.1 INTRODUCTION
8.2 HOSPITALS & CARDIAC CENTERS
8.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE END USER SEGMENT
8.3 AMBULATORY SURGERY CENTERS
8.3.1 INCREASING NUMBER OF AMBULATORY SURGICAL CENTERS IN THE US TO DRIVE ADOPTION OF ELECTROPHYSIOLOGY DEVICES
9 ELECTROPHYSIOLOGY MARKET, BY REGION (Page No. - 110)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 Technological advancements to drive market growth
9.2.2 CANADA
9.2.2.1 Growing government funding for research to support market growth
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Rising healthcare expenditure and growing use of electrophysiology devices to drive market growth
9.3.2 UK
9.3.2.1 Growing geriatric population to drive market growth
9.3.3 FRANCE
9.3.3.1 Increasing incidence of heart failure to support market growth
9.3.4 ITALY
9.3.4.1 Rising incidence of CVDs to drive electrophysiology devices adoption
9.3.5 SPAIN
9.3.5.1 Growing number of cardiac ablation procedures to drive market growth
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.1.1 Favorable reimbursement scenario to support market growth
9.4.2 CHINA
9.4.2.1 Growing geriatric population to drive market growth
9.4.3 INDIA
9.4.3.1 Increasing healthcare initiatives by government to drive market growth
9.4.4 AUSTRALIA
9.4.4.1 Increasing target disease burden to support market growth
9.4.5 SOUTH KOREA
9.4.5.1 Supportive government initiatives to drive market growth
9.4.6 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 BRAZIL
9.5.1.1 Modernization of healthcare facilities to drive market growth
9.5.2 MEXICO
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
9.5.3 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE (Page No. - 179)
10.1 INTRODUCTION
10.2 REVENUE SHARE ANALYSIS
10.3 MARKET SHARE ANALYSIS
10.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020)
10.4.1 STARS
10.4.2 EMERGING LEADERS
10.4.3 PERVASIVE PLAYERS
10.4.4 PARTICIPANTS
10.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (AS OF 2020)
10.5.1 PROGRESSIVE COMPANIES
10.5.2 RESPONSIVE COMPANIES
10.5.3 DYNAMIC COMPANIES
10.5.4 STARTING BLOCKS
10.6 COMPETITIVE BENCHMARKING
10.7 COMPETITIVE SCENARIO (2018-2021)
10.7.1 PRODUCT LAUNCHES
10.7.2 APPROVALS
10.7.3 DEALS
11 COMPANY PROFILES (Page No. - 196)
11.1 KEY PLAYERS
11.1.1 ABBOTT
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.4 MnM view
11.1.1.4.1 Right to win
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weakness and competItive treats
11.1.1.4.4 COVID-19 impact
11.1.2 MEDTRONIC
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.4 MnM view
11.1.2.4.1 Right to Win
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weakness and competitive treats
11.1.2.4.4 COVID-19 impact
11.1.3 BOSTON SCIENTIFIC CORPORATION
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.4 KONINKLIJKE PHILIPS N.V.
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.5 GE HEALTHCARE
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.6 SIEMENS HEALTHINEERS
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.7 STEREOTAXIS, INC.
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.8 MERIT MEDICAL SYSTEMS
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.9 ATRICURE INC.
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.10 APN HEALTH, LLC
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.11 OSYPKA MEDICAL
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.12 JAPAN LIFELINE CO., LTD.
11.1.12.1 Business overview
11.1.12.2 Products offered
11.1.12.3 Recent developments
11.1.13 JOHNSON & JOHNSON
11.1.13.1 Business overview
11.1.13.2 Products offered
11.1.13.3 Recent developments
11.1.13.4 MnM view
11.1.13.4.1 Right to win
11.1.13.4.2 Strategic choices
11.1.13.4.3 Weakness and competItive treats
11.1.13.4.4 COVID-19 impact
11.1.14 BIOTRONIK
11.1.14.1 Business overview
11.1.14.2 Products offered
11.1.14.3 Recent developments
11.1.15 MICROPORT SCIENTIFIC CORPORATION
11.1.15.1 Business overview
11.1.15.2 Products offered
11.1.15.3 Recent developments
11.1.16 ACUTUS MEDICAL, INC.
11.1.16.1 Business overview
11.1.16.2 Products offered
11.1.16.3 Recent developments
11.2 OTHER PLAYERS
11.2.1 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
11.2.2 CATHRX LTD.
11.2.3 COOK MEDICAL
11.2.4 CATHVISION APS
11.2.5 TZ MEDICAL
11.2.6 TELEFLEX INCORPORATED
11.2.7 IMRICOR
11.2.8 CARDIOFOCUS
11.2.9 SCHWARZER CARDIOTEK GMBH
11.2.10 KARDIUM
11.2.11 EP SOLUTIONS SA
11.2.12 BIOSIG TECHNOLOGIES, INC. (BSGM)
11.2.13 COREMAP
11.2.14 EPMAP SYSTEM GMBH
12 APPENDIX (Page No. - 272)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
LIST OF TABLES (181 Tables)
TABLE 1 INCLUSIONS AND EXCLUSIONS
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 3 NEW ENTRANTS IN THE CARDIAC MAPPING SYSTEMS MARKET
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES
TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 8 CHINA (NPMA): CLASSIFICATION OF MEDICAL DEVICES
TABLE 9 CLASSIFICATION OF MEDICAL DEVICES BY PMDA
TABLE 10 MEDICAL REIMBURSEMENT CODES FOR 2022 (PHYSICIAN)
TABLE 11 MEDICAL REIMBURSEMENT CODES FOR 2022 (HOSPITAL OUTPATIENT)
TABLE 12 MEDICAL REIMBURSEMENT CODES FOR 2022 (HOSPITAL INPATIENT)
TABLE 13 TOP 10 PATENT OWNERS FOR ELECTROPHYSIOLOGY (JANUARY 2011 TO DECEMBER 2021)
TABLE 14 AVERAGE PRICE OF ELECTROPHYSIOLOGY PRODUCTS, BY DEVICE NAME, 2020 (USD)
TABLE 15 ELECTROPHYSIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 16 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 17 EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 18 EP LABORATORY DEVICES MARKET, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 19 EP LABORATORY DEVICES MARKET, BY END USER, 2019-2027 (USD MILLION)
TABLE 20 EP LABORATORY DEVICES MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 21 3D MAPPING SYSTEMS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 22 ELECTROPHYSIOLOGY RECORDING SYSTEMS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 23 RF ABLATION SYSTEMS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 24 ICE ULTRASOUND IMAGING SYSTEMS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 25 ELECTROPHYSIOLOGY X-RAY SYSTEMS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 26 ELECTROPHYSIOLOGY REMOTE MAGNETIC AND ROBOTIC NAVIGATION SYSTEMS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 27 EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 28 EP ABLATION CATHETERS MARKET, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 29 EP ABLATION CATHETERS MARKET, BY END USER, 2019-2027 (USD MILLION)
TABLE 30 EP ABLATION CATHETERS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 31 CRYOABLATION EP CATHETERS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 32 RF ABLATION CATHETERS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 33 MWA SYSTEMS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 34 LASER ABLATION SYSTEMS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 35 EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 36 EP DIAGNOSTIC CATHETERS MARKET, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 37 EP DIAGNOSTIC CATHETERS MARKET, BY END USER, 2019-2027 (USD MILLION)
TABLE 38 EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 39 CONVENTIONAL EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 40 ADVANCED EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 41 ULTRASOUND EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 42 ACCESS DEVICES MARKET, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 43 ACCESS DEVICES MARKET, BY END USER, 2019-2027 (USD MILLION)
TABLE 44 ACCESS DEVICES MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 45 OTHER PRODUCTS MARKET, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 46 OTHER PRODUCTS MARKET, BY END USER, 2019-2027 (USD MILLION)
TABLE 47 OTHER PRODUCTS MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 48 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 49 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 50 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY REGION, 2019-2027 (USD MILLION)
TABLE 51 ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY REGION, 2019-2027 (USD MILLION)
TABLE 52 ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE SYNDROME, BY REGION, 2019-2027 (USD MILLION)
TABLE 53 ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 54 ELECTROPHYSIOLOGY MARKET, BY END USER, 2019-2027 (USD MILLION)
TABLE 55 ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 56 ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 57 ELECTROPHYSIOLOGY MARKET, BY REGION, 2019-2027 (USD MILLION)
TABLE 58 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 60 NORTH AMERICA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 61 NORTH AMERICA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 62 NORTH AMERICA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 63 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 64 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019-2027 (USD MILLION)
TABLE 65 CLINICAL TRIALS RELATED TO ELECTROPHYSIOLOGY DEVICES
TABLE 66 US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 67 US: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 68 US: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 69 US: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 70 RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY
TABLE 71 CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 72 CANADA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 73 CANADA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 74 CANADA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 75 EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76 EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 77 EUROPE: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 78 EUROPE: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 79 EUROPE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 80 EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 81 EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019-2027 (USD MILLION)
TABLE 82 GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 83 GERMANY: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 84 GERMANY: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 85 GERMANY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 86 UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 87 UK: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 88 UK: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 89 UK: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 90 FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 91 FRANCE: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 92 FRANCE: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 93 FRANCE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 94 ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 95 ITALY: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 96 ITALY: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 97 ITALY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 98 SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 99 SPAIN: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 100 SPAIN: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 101 SPAIN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 102 CARDIAC AF ABLATION PROCEDURES, BY COUNTRY, 2015 VS. 2016
TABLE 103 ROE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 104 ROE: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 105 ROE: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 106 ROE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 107 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 108 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 109 ASIA PACIFIC: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 110 ASIA PACIFIC: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 111 ASIA PACIFIC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 112 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 113 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019-2027 (USD MILLION)
TABLE 114 JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 115 JAPAN: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 116 JAPAN: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 117 JAPAN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 118 CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 119 CHINA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 120 CHINA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 121 CHINA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 122 INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 123 INDIA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 124 INDIA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 125 INDIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 126 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 127 AUSTRALIA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 128 AUSTRALIA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 129 AUSTRALIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 130 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 131 SOUTH KOREA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 132 SOUTH KOREA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 133 SOUTH KOREA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 134 ROAPAC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 135 ROAPAC: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 136 ROAPAC: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 137 ROAPAC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 138 LATAM: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 139 LATAM: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 140 LATAM: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 141 LATAM: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 142 LATAM: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 143 LATAM: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 144 LATAM: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019-2027 (USD MILLION)
TABLE 145 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 146 BRAZIL: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 147 BRAZIL: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 148 BRAZIL: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 149 MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 150 MEXICO: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 151 MEXICO: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 152 MEXICO: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 153 ROLA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 154 ROLA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 155 ROLA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 156 ROLA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 157 MEA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 158 MEA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 159 MEA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 160 MEA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019-2027 (USD MILLION)
TABLE 161 MEA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 162 MEA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019-2027 (USD MILLION)
TABLE 163 ELECTROPHYSIOLOGY MARKET: DEGREE OF COMPETITION
TABLE 164 PRODUCT FOOTPRINT ANALYSIS OF TOP PLAYERS IN ELECTROPHYSIOLOGY MARKET
TABLE 165 COMPANY FOOTPRINT ANALYSIS IN ELECTROPHYSIOLOGY MARKET
TABLE 166 ABBOTT: BUSINESS OVERVIEW
TABLE 167 MEDTRONIC: BUSINESS OVERVIEW
TABLE 168 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
TABLE 169 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
TABLE 170 GE HEALTHCARE: BUSINESS OVERVIEW
TABLE 171 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
TABLE 172 STEREOTAXIS, INC.: BUSINESS OVERVIEW
TABLE 173 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
TABLE 174 ATRICURE, INC.: BUSINESS OVERVIEW
TABLE 175 APN HEALTH, LLC: BUSINESS OVERVIEW
TABLE 176 OSYPKA MEDICAL: BUSINESS OVERVIEW
TABLE 177 JAPAN LIFELINE CO., LTD.: BUSINESS OVERVIEW
TABLE 178 JOHNSON & JOHNSON: BUSINESS OVERVIEW
TABLE 179 BIOTRONIK: BUSINESS OVERVIEW
TABLE 180 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
TABLE 181 ACUTUS MEDICAL, INC.: BUSINESS OVERVIEW
LIST OF FIGURES (44 Figures)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 4 MARKET SIZE ESTIMATION: VENDOR REVENUE-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: END USER-BASED MARKET ESTIMATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION)
FIGURE 8 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021 VS. 2027 (USD MILLION)
FIGURE 9 ELECTROPHYSIOLOGY MARKET, BY END USER, 2021 VS. 2027 (USD MILLION)
FIGURE 10 ASIA PACIFIC MARKET TO HAVE HIGHEST CAGR DURING FORECAST PERIOD (2022-2027)
FIGURE 11 TECHNOLOGICAL ADVANCEMENTS TO DRIVE GLOBAL ELECTROPHYSIOLOGY MARKET GROWTH
FIGURE 12 ATRIAL FIBRILLATION SEGMENT DOMINATED ELECTROPHYSIOLOGY MARKET IN 2021 BY INDICATION
FIGURE 13 ELECTROPHYSIOLOGY LABORATORY DEVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 IN PRODUCT SEGMENT
FIGURE 14 HOSPITALS & CARDIAC CENTERS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 15 BY END USER 2021 VS 2027
FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD (2022-2027)
FIGURE 17 ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 18 NUMBER OF PATENTS ISSUED (2011 -2021)
FIGURE 19 TOP 10 PATENTS OWNERS FOR ELECTROPHYSIOLOGY (JANUARY 2011 TO DECEMBER 2021)
FIGURE 20 TOP 10 PATENT APPLICANTS FOR ELECTROPHYSIOLOGY (JANUARY 2011 TO DECEMBER 2021)
FIGURE 21 PATENTS FOR ELECTROPHYSIOLOGY, BY JURISDICTION (JANUARY 2011 TO DECEMBER 2021)
FIGURE 22 VALUE CHAIN OF ELECTROPHYSIOLOGY MARKET
FIGURE 23 ELECTROPHYSIOLOGY MARKET: ECOSYSTEM LANDSCAPE
FIGURE 24 GEOGRAPHIC SNAPSHOT OF ELECTROPHYSIOLOGY MARKET
FIGURE 25 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT
FIGURE 26 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT
FIGURE 27 KEY DEVELOPMENTS BY LEADING PLAYERS IN ELECTROPHYSIOLOGY MARKET, 2018-2021
FIGURE 28 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN ELECTROPHYSIOLOGY MARKET
FIGURE 29 ELECTROPHYSIOLOGY MARKET SHARE, BY KEY PLAYER, 2020
FIGURE 30 ELECTROPHYSIOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
FIGURE 31 ELECTROPHYSIOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) (2020)
FIGURE 32 ABBOTT: COMPANY SNAPSHOT (2020)
FIGURE 33 MEDTRONIC: COMPANY SNAPSHOT (2021)
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
FIGURE 35 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
FIGURE 36 GE HEALTHCARE: COMPANY SNAPSHOT (2020)
FIGURE 37 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020)
FIGURE 38 STEREOTAXIS: COMPANY SNAPSHOT (2020)
FIGURE 39 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2020)
FIGURE 40 ATRICURE, INC.: COMPANY SNAPSHOT (2020)
FIGURE 41 JAPAN LIFELINE CO., LTD.: COMPANY SNAPSHOT (2020)
FIGURE 42 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)
FIGURE 43 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
FIGURE 44 ACUTUS MEDICAL INC.: COMPANY SNAPSHOT (2020)
